The Foundation supports research that can lead to the creation of better Parkinson's treatments. Here you can search previously awarded grants by keyword, program name, researcher name, institution or organization name and/or year.
FUNDED GRANTS ( 3)
Target Advancement Program, 2016
People who have mutations in the GBA1 gene have a higher chance of developing Parkinson's disease (PD) but it is unclear why. We found that GBA1 mutations affect the cellular ability to clear proteins by disrupting regulation of the lysosomes. The lysosomes are responsible for recycling cellular components and inability to do this function can lead to neuronal death. Both levels an...
Researchers: Ola A. Awad, MBBCh, MSc, PhD
Improving Delivery of Parkinson's Disease Therapeutics to th, 2008
Current drug therapy for Parkinson’s disease has limited long term effectiveness. To improve therapy in the future, delivery of therapeutic agents to the brain will be an increasingly important means of treating PD. Current neurosurgical procedures are essentially blind, leading to errors in targeting desired brain structures and in delivery. For emerging therapeutics, such a...
Dopamine-Non-Responsive Symptoms of Parkinson's Disease, 2006
Gait impairment resulting in loss of mobility is a major cause of disability in Parkinson's disease, and current therapy including levodopa, surgery and rehabilitation are inadequate to preserve mobility as PD progresses. This study will compare the efficacy of 3 exercise regimens for gait-related disability: 1) treadmill training with aerobic exercise, 2) treadmill training without aerobic exerci...